Medicines Transparency Alliance22/04/23 1

MeTA in the Philippines

Catherine DauphinTechnical officerWHO Country Office for the Philippines

Medicines Transparency Alliance22/04/23 2

Inception April 2007: DFID-WHO scoping work Working group of international partners (WHO, EU, WB, GTZ)

and the Department of Health to set-up the MeTA council Philippines

December 2007: MeTA Philippines official launch with the first national MeTA forum

October 2010: end of MeTA pilot phase

Medicines Transparency Alliance

MeTA framework in the Philippines Quarterly meeting of a Council of 24 members body with

multistakeholder representation:– Government– Academe– Professional groups (pharmacists, doctors, pharmaceutical industry

associations)– Civil society– International partners

Monthly meetings of the Executive Committee:– Chairman,– vice-chairman,– secretary, – treasurer, – heads of technical committees (advocacy and partnership, finance,

membership, research) A secretariat: secretary + admin assistant + webmaster

Medicines Transparency Alliance

MeTA goals in the Philippines Purpose To make information available and to establish

systems and mechanisms for transparency along medicines registration, selection, procurement and use

Specific Objectives– Making available information on quality and registration of medicines,

availability, pricing, ethical promotion and national and local policies on access to essential medicines

– Setting up of structures and systems for disclosure of information at the national and local government levels

– Improving technical capacity for disclosing, analyzing and using information and evidence in decision-making

– Setting up mechanisms for advocacy and participation in decision-making processes (“getting the message out”)

– Sustaining multi-stakeholder collaboration

Medicines Transparency Alliance

Making information available

Building a common understanding Using standardized tools…

– Pharmaceutical context - Pharmaceutical Sector Scan– Regulatory context - Disclosure survey– Access to medicines assessment - WHO facility and household surveys

and ad hoc surveys– Medicines financing mechanism for the poor – Promotional practices

Medicines Transparency Alliance

Improving systems and capacity for information disclosure and evidence use in decision making

Regional Consultation on the Electronic Essential Drug Price Monitoring System (eEDPMS) 

Multi-Stakeholder Workshops on Ethical Drug Promotions and Marketing

Medicines Transparency Alliance

Contribution to the WHO Good Governance on Medicines Awards Pharmaceutical Management and Good Governance Course for

LGU Health Managers and Local Chief Executives Workshop for finalizing Core Indicators and Survey Tools for a

Pharmacy Benchbook

Improving systems and capacity for information disclosure and evidence use in decision making

Medicines Transparency Alliance

Set up mechanisms for advocacy and participation in decision-making processes MeTA Roundtable Discussions / MeTA

Discussion Series:

Publications of researches, studies and proceedings

MeTA Philippines Website

3 annual MeTA forums

2 national summits on Transparency and Governance in Universal Health Care

TV Documentary on Universal Health Care

Trips+ position paper and advocacy meeting

Medicines Transparency Alliance

Conclusions and next steps Major achievement:

– built and sustain a multistakeholder dialogue– establish a common understanding of access to medicines– Get the message out

MeTA ability to influence policy is difficult to measure:– 2 years pilot mainly dedicated to build trust and background analysis– How do we measure influence?– Where do we set the expectations?

MeTA 2:– 1 week visit of the International Secretariat to work on MeTA2 framework in

the Philipines (Nov 21st – Nov 25th)– Consultation and elaboration of MeTA 2 workplan by January 2012

Medicines Transparency Alliance22/04/23 10

Thank you Catherine Dauphin Email:dauphinc@wpro.who.int MeTA Philippines website: www.metaphilippines.org.ph